Carregant...

Effects of empagliflozin and target-organ damage in a novel rodent model of heart failure induced by combined hypertension and diabetes

Type 2 diabetes mellitus and hypertension are two major risk factors leading to heart failure and cardiovascular damage. Lowering blood sugar by the sodium-glucose co-transporter 2 inhibitor empagliflozin provides cardiac protection. We established a new rat model that develops both inducible diabet...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Kräker, Kristin, Herse, Florian, Golic, Michaela, Reichhart, Nadine, Crespo-Garcia, Sergio, Strauß, Olaf, Grune, Jana, Kintscher, Ulrich, Ebrahim, Manal, Bader, Michael, Alenina, Natalia, Heuser, Arnd, Luft, Friedrich C., Müller, Dominik N., Dechend, Ralf, Haase, Nadine
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7441148/
https://ncbi.nlm.nih.gov/pubmed/32820187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-70708-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!